Telemedicine Companies Providing Prescription-Only Medications: Pros, Cons, and Proposed Guidelines.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31599848.
- Also identified by DOI 10.1097/AOG.0000000000003529.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the past few years, there has been a significant increase in the number of direct-to-consumer telehealth companies offering prescription medications to women. Leveraging technology, these companies have the potential to improve access to care and ensure that women have access to prescription-only medications in a convenient fashion. However, it is important to ensure that they are doing so in a safe, patient-centered way that observes evidence-based prescribing guidelines. In this article, we discuss the pros and cons of direct-to-consumer telehealth companies offering prescription medicine and suggest several guidelines to ensure that women are being cared for in an appropriate way.
Medical subject headings
- Pharmaceutical Services
- Telemedicine
- Women's Health Services